There were also no significant differences in the TILs expansion associated with different patient groups (age, gender, stage of disease at diagnosis, staging as per the International Neuroblastoma Risk Group (INRG) Classification System, MYC-N amplification, and presence of segmental chromosomal aberrations). Here, MYC is linked to neuroblastoma.